Tiziana Vavalà

Tiziana Vavalà

UNVERIFIED PROFILE

Are you Tiziana Vavalà?   Register this Author

Register author
Tiziana Vavalà

Tiziana Vavalà

Publications by authors named "Tiziana Vavalà"

Are you Tiziana Vavalà?   Register this Author

19Publications

631Reads

9Profile Views

Alectinib in the treatment of ALK-positive non-small cell lung cancer: an update on its properties, efficacy, safety and place in therapy.

Ther Adv Med Oncol 2018 3;10:1758835918789364. Epub 2018 Aug 3.

Department of Oncology, University of Torino, AOU S. Luigi Gonzaga, Regione Gonzole 10, Orbassano (TO), Turin, Orbassano 10043, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1758835918789364DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6077883PMC
August 2018

Management of Leptomeningeal Metastases in Non-oncogene Addicted Non-small Cell Lung Cancer.

Front Oncol 2018 27;8:278. Epub 2018 Jul 27.

Department of Oncology, University of Torino, Ospedale San Luigi Gonzaga, Orbassano, Italy.

View Article

Download full-text PDF

Source
https://www.frontiersin.org/article/10.3389/fonc.2018.00278/
Publisher Site
http://dx.doi.org/10.3389/fonc.2018.00278DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6094962PMC
July 2018

Role of afatinib in the treatment of advanced lung squamous cell carcinoma.

Authors:
Tiziana Vavalà

Clin Pharmacol 2017 27;9:147-157. Epub 2017 Nov 27.

ASL CN1, SC Oncologia, Ospedale Civile di Saluzzo, Saluzzo, Cuneo, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2147/CPAA.S112715DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5709991PMC
November 2017

Adjuvant Therapy of Resected Non-small Cell Lung Cancer: can We Move Forward?

Curr Treat Options Oncol 2016 10;17(10):54

Department of Oncology at San Luigi Hospital, University of Turin, Regione Gonzole 10, 10043, Orbassano, Torino, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11864-016-0429-xDOI Listing
October 2016

EGFR Fusions as Novel Therapeutic Targets in Lung Cancer.

Cancer Discov 2016 06 21;6(6):601-11. Epub 2016 Apr 21.

Department of Cancer Biology, Vanderbilt University Medical Center, Nashville, Tennessee. Addario Lung Cancer Medical Institute, Cambridge, Massachusetts. Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee. Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/2159-8290.CD-16-0075DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4893907PMC
June 2016

An overview of angiogenesis inhibitors in Phase II studies for non-small-cell lung cancer.

Expert Opin Investig Drugs 2015 12;24(9):1143-61. Epub 2015 Jun 12.

University of Verona Azienda Ospedaliera Universitaria Integrata, Medical Oncology , P.le L.A. Scuro 10, 37124, Verona , Italy +390 458 128 124 ; +390 458 027 410 ;

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1517/13543784.2015.1056341DOI Listing
April 2016

Safety and diagnostic performance of image-guided lung biopsy in the targeted therapy era.

Radiol Med 2015 Nov 1;120(11):1024-30. Epub 2015 May 1.

Radiology Unit, Department of Oncology, University of Torino, Regione Gonzole 10, 10043, Orbassano, TO, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11547-015-0538-9DOI Listing
November 2015

ATF2 contributes to cisplatin resistance in non-small cell lung cancer and celastrol induces cisplatin resensitization through inhibition of JNK/ATF2 pathway.

Int J Cancer 2015 Jun 12;136(11):2598-609. Epub 2014 Nov 12.

Department of Oncology, University of Turin, S. Luigi Hospital, Regione Gonzole 10, Orbassano, Turin, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ijc.29302DOI Listing
June 2015

Impact of non-small-cell lung cancer-not otherwise specified immunophenotyping on treatment outcome.

J Thorac Oncol 2014 Oct;9(10):1540-6

*Department of Oncology, University of Turin at San Luigi Hospital, Orbassano, Torino; and †Division of Pathology, University of Modena, Modena, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0000000000000271DOI Listing
October 2014

Maintenance therapy in NSCLC: why? To whom? Which agent?

J Exp Clin Cancer Res 2011 May 6;30:50. Epub 2011 May 6.

Thoracic Oncology Unit, University of Turin, AOU, San Luigi Orbassano, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1756-9966-30-50DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3113744PMC
May 2011

Lung cancer and women.

Future Oncol 2008 Oct;4(5):705-16

Department of Clinical & Biological Sciences, S Luigi Hospital, University of Torino, Orbassano, Torino, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/14796694.4.5.705DOI Listing
October 2008